keyboard_arrow_right
Search keyboard_arrow_right
keyboard_arrow_left Hide
LIVE DAY 2 ✦ Oct. 13 - EDT
search
LIVE DAY 2 ✦ Oct. 13 - EDT
search
7:30am - 8:15am45 mins
Registration and Breakfast - Exhibit Area - Atrium
General Session
8:15am - 8:30am15 mins
General Session
Chairperson's Opening Remarks
- Katherine Chaurette - Senior Vice President, Healthcare Law and Compliance, Blueprint Medicines
8:30am - 9:10am40 mins
General Session
State of the Industry: Drug Pricing and Managed Care Programs in the US - from the Payer Perspective
9:10am - 9:50am40 mins
General Session
Congressional Insights Keynote: Proposed Legislation and Policy Updates from the Senate Committee on Finance
- Anna Kaltenboeck - Senior Health Advisor, Senate Committee on Finance, Chairman Ron Wyden (D-Ore.)
9:50am - 10:30am40 mins
General Session
Navigating PBMs and Vertically Integrated Customers
- Rujul Desai - Of Counsel, Covington & Burling LLP
10:30am - 11:00am30 mins
General Session
Morning Networking and Refreshment Break - Exhibit Area - Atrium
11:00am - 11:30am30 mins
General Session
Presentation Title TBD
- Alice Valder Curran - Partner, Hogan Lovells US LLP
11:30am - 12:10pm40 mins
General Session
Multiple Best Price Strategies to Operationalize the Value-Based Purchasing Final Rule
- Jeff Baab - Vice President, Operational Consulting, IntegriChain
- John Gould - Partner, Arnold & Porter
12:10pm - 1:00pm50 mins
General Session
Ask the Attorney's: What Keeps Them Up at Night?
- Michael Kurland - Vice President, Revenue Management & Compliance, EVERSANA
- Christopher Schott - Partner, Latham & Watkins
- Stephanie Trunk - Partner, ArentFox Schiff
- John Shakow - Partner, King & Spalding
1:00pm - 2:10pm70 mins
General Session
Networking Lunch and Visit the Exhibit Hall
Track Sessions
2:10pm - 2:15pm5 mins
Track A: Implications of Recent Rules and Proposed Regulations
Chairperson's Remarks
2:10pm - 2:15pm5 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
Chairperson's Remarks
2:10pm - 2:15pm5 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Chairperson's Remarks
2:15pm - 3:00pm45 mins
Track A: Implications of Recent Rules and Proposed Regulations
AMP Cap Removal: The Who, What, How
- Jesse Mendelsohn - Vice President, Centers of Excellence, Model N
- Mohammed Khan - Senior Manager, Deloitte & Touche
- Brian McCartney - Senior Director, Market Access Policy & Government Reporting, AstraZeneca
2:15pm - 3:00pm45 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
Panel: 340B Thought Leadership - What's New and What's Next
- Katheryne Richardson, PharmD - Executive Director and Head US 340B Strategy, Bristol Myers Squibb
- Tess Morgan - Senior Manager, Product Diversion and Program Integrity, Pfizer
- Katy Lees - Director of 340B Policy and Business Strategy, University of Rochester Medicine
2:15pm - 2:55pm40 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Roadmap to a successful product launch
- Walt Worsham - Managing Director, Federal Compliance Solutions LLC
- Felecia Manning - Director, Managed Markets Contracts & Government Pricing, United Therapeutics Corporation
- Rick Moore - Managing Partner, Federal Compliance Solutions LLC
2:55pm - 3:40pm45 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Acquisitions and Divestitures for Emerging, Small and Mid-Sized Pharma
- Dana Collins - Director, Helio Health Group
- Matthew Fornataro - Partner, Arnold & Porter
- Melody Hamel - Senior Operations Counsel, Viatris
3:00pm - 3:40pm40 mins
Track A: Implications of Recent Rules and Proposed Regulations
Bona Fide Service Fees and Fair Market Value Updates and Strategies
- Nick Lynch, CFE - Partner, Federal Compliance Solutions LLC
3:00pm - 3:40pm40 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
340B Litigation Updates
- William Sarraille - Partner, Sidley Austin LLP
3:40pm - 4:10pm30 mins
Track A: Implications of Recent Rules and Proposed Regulations
Afternoon Networking Break
3:40pm - 4:10pm30 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
Afternoon Networking Break
3:40pm - 4:10pm30 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Afternoon Networking Break
4:10pm - 4:50pm40 mins
Track A: Implications of Recent Rules and Proposed Regulations
Line Extensions: The Operational Nightmare
- Ruth Nunez - Senior Manager, US Government Pricing, Pfizer
- Shrutej Patel - Director, Government Reporting, Novartis
4:10pm - 4:50pm40 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
State Legislation Review: 340B
4:10pm - 4:50pm40 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Panel: Pricing Committee Development and Refresh
- Tom Evegan - Principal, Strategy & Management Consulting, RSM US LLP
- Rosalind Davis - Director, Government Pricing & Contracts, Vifor Pharma, Inc.
- Lisa Kiniklis - Senior Director, Market Access Operations, Contracting and Pricing, Deciphera Pharmaceuticals
- Marcella Lynch - Director, Forecasting and Pricing - Market Access, Rare Diseases, Chiesi USA, Inc.
4:50pm - 5:35pm45 mins
Track A: Implications of Recent Rules and Proposed Regulations
The Future of Drug Pricing Demonstration Programs
- Margaux Hall - Partner, Ropes & Gray LLP
- Stephanie Webster - Partner, Ropes & Gray
- David Ault - Counsel, Ropes & Gray
4:50pm - 5:35pm45 mins
Track B: 30 Year Anniversary of 340B - Policy, Reform and Operationalizing the Program
Panel: The Dreaded Duplicate Discounts - Collaborating in the New Hybrid Working Landscape
4:50pm - 5:35pm45 mins
Track C: Practical Strategies for Emerging, Small, and Mid-Size Companies
Panel: Best Practices for Accurate Inputs into Government Pricing
- Scott Hoffman - Head of Client Services, Woven Data
- Megan Falkowski - Director, Government Pricing & Government Contracting Policy, Pfizer Inc
- Stephanie Kupski - Director, U.S. Pricing & Government Reporting, CSL Behring
5:35pm - 6:35pm60 mins
Evening Reception and Visit the Exhibit Hall